APA (7th ed.) Citation

Sreenath, N. D., Pandalanghat, S., Kapoor, A., Govind, R., Kaushik, M. R., Nair, R., . . . Mulajker, D. A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: A prospective mid term follow-Up study from an Indian cohort. BMC.

Chicago Style (17th ed.) Citation

Sreenath, Nihanthy D., et al. A Comparative Analysis of Palbociclib and Ribociclib in Metastatic Hormone Receptor-positive, HER2-negative Breast Cancer: A Prospective Mid Term Follow-Up Study from an Indian Cohort. BMC.

MLA (9th ed.) Citation

Sreenath, Nihanthy D., et al. A Comparative Analysis of Palbociclib and Ribociclib in Metastatic Hormone Receptor-positive, HER2-negative Breast Cancer: A Prospective Mid Term Follow-Up Study from an Indian Cohort. BMC.